Despite current flexibility, future enforcement could prove to be troublesome
Researchers share that perfluorohexyloctane eye drops offer rapid relief for dry eye disease, enhancing patient comfort before cataract surgery.
Clinician-scientists play a vital role in advancing ophthalmology by balancing patient care with research, leveraging clinical insights to drive impactful discoveries, and collaborating across disciplines to stay at the forefront of innovation.
Laxmi Devisetty, MD, and Eva Kim, MD, look ahead at upcoming sessions focusing on geographic atrophy and refractive and cataract surgery at the Envision Summit 2025.
Bi-sign design compensates for aberrations resulting from misalignment.
Noncontact esthesiometry screens for all levels of neurotrophic keratitis.
Growing patient pool is driving clinical trial investment.
Yvonne Ou, MD, a professor of ophthalmology at the University of California San Francisco, spoke about lifestyle modifications for glaucoma at this year's Glaucoma 360 meeting.
Researchers introduce a multistage dual-branch network to improve accuracy and efficiency
Research explores innovative physiotherapeutic approaches to managing myopia progression, showing promising results in slowing its advancement over two years.
Adrienne Graves, PhD, and Andrew Iwach, MD, co-founders of Glaucoma 360, highlight the 13th annual Glaucoma 360 New Horizons Forum, held this year at the Westin St. Francis San Francisco on Union Square.
Katrina Ronne shares her vision to empower ophthalmologists, champion equity, and strengthen advocacy for better eye health outcomes across Australia.
Physicians should consider the roles of verbal and ocular anesthesia.
Case of anterior segment ischemia involves young adult with prior carotid artery injury.
Discover how advocacy can impact your clinical work and ultimately patient care.
Removing drops from procedure increases adherence and comfort for most patients.
Staging AMD accurately and identifying clinical features that are linked with disease progression are key.
Over the years, IKA has become an invaluable resource for eye care professionals.
From revised patient flow to smarter tech adoption, ophthalmologists share which changes from 2020 have become cornerstones of modern care—and how they’re preparing for the next big disruption
Evidence-based medicine can lead to personalized care, better results for patients
At ARVO 2025, in Salt Lake City, Utah, Alex Choi discussed his poster on APOE carrier genetic status and its relation to Alzheimer disease as well as changes of the retina that might reflect early signs leading to an earlier diagnosis of the disease
Technical details, communication style key to presbyopia-correcting IOL journey.
Optimizing corneal neurotization outcomes with cryopreserved amniotic membrane.
Research can drive opportunities for patients with rare diseases
Considerations in the treatment of diabetic retinopathy and diabetic macular edema.
These tools help fill a gap that current technologies cannot achieve as effectively.
Epi-on corneal crosslinking is advancing through innovations like supplemental oxygen, chemical oxygenation, and laser-assisted techniques.
Grazia Pertile, MD, discusses the highlights of her presentations on the management of retinal folds after retinal detachment and the role of the anterior vitreous as a cause of recurrent retinal detachment.
At ARVO 2025, in Salt Lake City, Utah, Patipol Tiyajamorn, talked about his poster on using graph neural networks to identify fast glaucoma progressors solely using optic nerve head morphology at a single time point